scholarly article | Q13442814 |
P2093 | author name string | Khalid Hussain | |
Hüseyin Demirbilek | |||
Sara Al-Khawaga | |||
Sonya Galcheva | |||
P2860 | cites work | Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor | Q24304448 |
Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome) | Q24318956 | ||
Phosphoglucomutase 1: a gene with two promoters and a duplicated first exon | Q24322078 | ||
Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia | Q24324798 | ||
Control of pancreas and liver gene expression by HNF transcription factors | Q24618003 | ||
Hyperinsulinemic Hypoglycemia - The Molecular Mechanisms | Q26749617 | ||
Conformational transition pathway in the activation process of allosteric glucokinase | Q27316020 | ||
Why expression of some genes is disallowed in beta-cells. | Q40091519 | ||
Congenital hyperinsulinism caused by hexokinase I expression or glucokinase-activating mutation in a subset of β-cells | Q40123629 | ||
Severe congenital hyperinsulinism caused by a mutation in the Kir6.2 subunit of the adenosine triphosphate-sensitive potassium channel impairing trafficking and function | Q40401603 | ||
The carbohydrate-deficient glycoprotein syndromes: pre-Golgi and Golgi disorders? | Q40803578 | ||
Glucose counterregulation: prevention and correction of hypoglycemia in humans | Q40883259 | ||
High Incidence of Heterozygous ABCC8 and HNF1A Mutations in Czech Patients With Congenital Hyperinsulinism | Q41270328 | ||
News on Clinical Details and Treatment in PGM1-CDG | Q41590952 | ||
A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels | Q41644878 | ||
Paternally inherited ABCC8 mutation causing diffuse congenital hyperinsulinism. | Q41949686 | ||
Congenital hyperinsulinism and Poland syndrome in association with 10p13-14 duplication | Q42030143 | ||
A Novel Intragenic SLC16A1 Mutation Associated With Congenital Hyperinsulinism | Q42114467 | ||
A CACNA1D mutation in a patient with persistent hyperinsulinaemic hypoglycaemia, heart defects, and severe hypotonia | Q42349723 | ||
Glucokinase mutation-a rare cause of recurrent hypoglycemia in adults: a case report and literature review | Q42376697 | ||
Mutations in the NSD1 gene in patients with Sotos syndrome associate with endocrine and paracrine alterations in the IGF system | Q42467438 | ||
Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action | Q42504879 | ||
Molecular characterisation of glutamate dehydrogenase gene defects in Japanese patients with congenital hyperinsulinism/hyperammonaemia | Q42517221 | ||
Loss of functional KATP channels in pancreatic beta-cells causes persistent hyperinsulinemic hypoglycemia of infancy | Q42527683 | ||
ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism | Q42946308 | ||
HNF4A mutation: switch from hyperinsulinaemic hypoglycaemia to maturity-onset diabetes of the young, and incretin response | Q43117875 | ||
Systemic activation of glutamate dehydrogenase increases renal ammoniagenesis: implications for the hyperinsulinism/hyperammonemia syndrome | Q43120649 | ||
Identification of a familial hyperinsulinism-causing mutation in the sulfonylurea receptor 1 that prevents normal trafficking and function of KATP channels | Q43898224 | ||
Compound heterozygosity for the common sulfonylurea receptor mutations can cause mild diazoxide-sensitive hyperinsulinism | Q43985793 | ||
Foxa2 controls Pdx1 gene expression in pancreatic beta-cells in vivo. | Q44081011 | ||
Regulation of leucine-stimulated insulin secretion and glutamine metabolism in isolated rat islets | Q44223858 | ||
Physical exercise-induced hyperinsulinemic hypoglycemia is an autosomal-dominant trait characterized by abnormal pyruvate-induced insulin release | Q44262567 | ||
Clinical and molecular characterization of a dominant form of congenital hyperinsulinism caused by a mutation in the high-affinity sulfonylurea receptor | Q44564067 | ||
Assembly, maturation, and turnover of K(ATP) channel subunits | Q44709067 | ||
Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation | Q44995571 | ||
Glucokinase and glucose homeostasis: proven concepts and new ideas | Q45236084 | ||
Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing | Q45345386 | ||
3-Hydroxyacyl-coenzyme A dehydrogenase deficiency and hyperinsulinemic hypoglycemia: characterization of a novel mutation and severe dietary protein sensitivity. | Q46024776 | ||
Congenital disorder of glycosylation type Ia: heterogeneity in the clinical presentation from multivisceral failure to hyperinsulinaemic hypoglycaemia as leading symptoms in three infants with phosphomannomutase deficiency. | Q46035650 | ||
A novel KCNJ11 mutation associated with congenital hyperinsulinism reduces the intrinsic open probability of beta-cell ATP-sensitive potassium channels | Q27863904 | ||
Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations | Q27865219 | ||
Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism | Q28117072 | ||
Human short-chain L-3-hydroxyacyl-CoA dehydrogenase: cloning and characterization of the coding sequence | Q28118794 | ||
Molecular biology of adenosine triphosphate-sensitive potassium channels | Q28141603 | ||
Phosphomannomutase deficiency: the molecular basis of the classical Jaeken syndrome (CDGS type Ia) | Q28145985 | ||
Novel missense mutations outside the allosteric domain of glutamate dehydrogenase are prevalent in European patients with the congenital hyperinsulinism-hyperammonemia syndrome | Q28201951 | ||
Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells | Q28259615 | ||
Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene | Q28269681 | ||
Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1) | Q28298538 | ||
Tissue-specific deletion of Foxa2 in pancreatic beta cells results in hyperinsulinemic hypoglycemia | Q28343716 | ||
Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion | Q28345606 | ||
Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene | Q28469173 | ||
Foxa2 is required for the differentiation of pancreatic alpha-cells | Q28506877 | ||
Overexpression of monocarboxylate transporter-1 (SLC16A1) in mouse pancreatic β-cells leads to relative hyperinsulinism during exercise | Q28513468 | ||
The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion | Q28513687 | ||
Effects of N-glycosylation on protein conformation and dynamics: Protein Data Bank analysis and molecular dynamics simulation study. | Q30372497 | ||
Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. | Q32157821 | ||
Mutations in UCP2 in congenital hyperinsulinism reveal a role for regulation of insulin secretion | Q33391087 | ||
Opposite clinical phenotypes of glucokinase disease: Description of a novel activating mutation and contiguous inactivating mutations in human glucokinase (GCK) gene. | Q33642045 | ||
Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations | Q33803843 | ||
Practical management of hyperinsulinism in infancy | Q33844337 | ||
A significant portion of mitochondrial proton leak in intact thymocytes depends on expression of UCP2. | Q33896736 | ||
Hypoglycemia in Beckwith-Wiedemann syndrome | Q33901397 | ||
Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function | Q33966115 | ||
High residual activity of PMM2 in patients' fibroblasts: possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency). | Q34044174 | ||
The human monocarboxylate transporter, MCT1: genomic organization and promoter analysis | Q34123161 | ||
Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: the clinical relevance of an early diagnosis and report of four new cases. | Q34166580 | ||
Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase | Q34181596 | ||
Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion | Q34308492 | ||
Next-generation sequencing reveals deep intronic cryptic ABCC8 and HADH splicing founder mutations causing hyperinsulinism by pseudoexon activation | Q34319932 | ||
Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism | Q34361657 | ||
Glucose modulation of glucokinase activation by small molecules | Q46089715 | ||
Neurological aspects of hyperinsulinism-hyperammonaemia syndrome | Q46221266 | ||
Chromosome 11p15 paternal isodisomy in focal forms of neonatal hyperinsulinism | Q46363716 | ||
Hyperinsulinism in tyrosinaemia type I. | Q46475210 | ||
Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation | Q46616481 | ||
ATP enhances exocytosis of insulin secretory granules in pancreatic islets under Ca2+-depleted condition | Q46649104 | ||
Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations | Q46759019 | ||
Hepatocyte nuclear factor-4alpha is essential for glucose-stimulated insulin secretion by pancreatic beta-cells | Q46868194 | ||
An ABCC8 gene mutation and mosaic uniparental isodisomy resulting in atypical diffuse congenital hyperinsulinism | Q46945297 | ||
Congenital Hyperinsulinism: Diagnosis and Treatment Update | Q47894084 | ||
Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy | Q47903960 | ||
Molecular basis of the long-QT syndrome associated with deafness | Q48049583 | ||
Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3) | Q48056898 | ||
Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene | Q48150412 | ||
Analysis of large-scale sequencing cohorts does not support the role of variants in UCP2 as a cause of hyperinsulinaemic hypoglycaemia. | Q48169448 | ||
Heterogeneity in phenotype of hyperinsulinism caused by activating glucokinase mutations: a novel mutation and its functional characterization. | Q48181466 | ||
Expression of Calcium Channel mRNAs in Rat Pancreatic Islets and Downregulation After Glucose Infusion | Q48264512 | ||
Congenital central hypoventilation syndrome and hypoglycaemia | Q48273121 | ||
A severe case of hyperinsulinism due to hemizygous activating mutation of glutamate dehydrogenase | Q48273547 | ||
Mosaic Turner syndrome and hyperinsulinaemic hypoglycaemia | Q48298110 | ||
Novel FOXA2 mutation causes Hyperinsulinism, Hypopituitarism with Craniofacial and Endoderm-derived organ abnormalities | Q49653037 | ||
A case of CHARGE syndrome associated with hyperinsulinemic hypoglycemia in infancy | Q49884842 | ||
Could a combination of heterozygous ABCC8 and KCNJ11 mutations cause congenital hyperinsulinism? | Q50060793 | ||
Congenital Hyperinsulinism and Hypopituitarism Attributable to a Novel Mutation in FOXA2. | Q50062725 | ||
Nutrient sensing in pancreatic islets: lessons from congenital hyperinsulinism and monogenic diabetes | Q50088043 | ||
Polycystic Kidney Disease with Hyperinsulinemic Hypoglycemia Caused by a Promoter Mutation in Phosphomannomutase 2. | Q50211745 | ||
Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy | Q37370991 | ||
Hyperinsulinism-hyperammonaemia syndrome: novel mutations in the GLUD1 gene and genotype-phenotype correlations | Q37387200 | ||
Hyperinsulinism in developmental syndromes | Q37417001 | ||
Dominant form of congenital hyperinsulinism maps to HK1 region on 10q. | Q37422505 | ||
Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time | Q37465263 | ||
Asymptomatic Congenital Hyperinsulinism due to a Glucokinase-Activating Mutation, Treated as Adrenal Insufficiency for Twelve Years | Q37598114 | ||
Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia | Q37605708 | ||
The structure and allosteric regulation of glutamate dehydrogenase | Q37808783 | ||
Genetics of congenital hyperinsulinemic hypoglycemia | Q37824089 | ||
KATP channel mutations in congenital hyperinsulinism | Q37824090 | ||
Morphological mosaicism of the pancreatic islets: a novel anatomopathological form of persistent hyperinsulinemic hypoglycemia of infancy | Q37940268 | ||
Novel insights into fatty acid oxidation, amino acid metabolism, and insulin secretion from studying patients with loss of function mutations in 3-hydroxyacyl-CoA dehydrogenase. | Q38068635 | ||
Integrating genetic and imaging investigations into the clinical management of congenital hyperinsulinism. | Q38076506 | ||
Metabolic signaling in fuel-induced insulin secretion | Q38116234 | ||
Low-level hyperinsulinism with hypoglycemic spells in an infant with mosaic Turner syndrome and mild Kabuki-like phenotype: a case report and review of the literature | Q38129372 | ||
Clinical and histological heterogeneity of congenital hyperinsulinism due to paternally inherited heterozygous ABCC8/KCNJ11 mutations | Q38247221 | ||
Molecular mechanisms of congenital hyperinsulinism | Q38367078 | ||
Hyperinsulinemic Hypoglycemia. | Q38554245 | ||
Biomarkers of Insulin for the Diagnosis of Hyperinsulinemic Hypoglycemia in Infants and Children. | Q38613445 | ||
Molecular mechanisms of congenital hyperinsulinism due to autosomal dominant mutations in ABCC8. | Q38861985 | ||
The Pancreatic β-Cell: A Bioenergetic Perspective | Q38943061 | ||
Hyperinsulinaemic hypoglycaemia in children and adults. | Q39028483 | ||
Novel Hypoglycemia Phenotype in Congenital Hyperinsulinism Due to Dominant Mutations of Uncoupling Protein 2. | Q39102009 | ||
Sar1-GTPase-dependent ER exit of KATP channels revealed by a mutation causing congenital hyperinsulinism | Q39862542 | ||
A novel congenital disorder of glycosylation type without central nervous system involvement caused by mutations in the phosphoglucomutase 1 gene. | Q50503545 | ||
Protein-induced hyperinsulinaemic hypoglycaemia due to a homozygous HADH mutation in three siblings of a Saudi family. | Q50589680 | ||
Focal congenital hyperinsulinism managed by medical treatment: a diagnostic algorithm based on molecular genetic screening. | Q51127204 | ||
Costello syndrome and hyperinsulinemic hypoglycemia. | Q51924302 | ||
Conditional Tissue-Specific Foxa2 Ablation in Mouse Pancreas Causes Hyperinsulinemic Hypoglycemia. | Q53175598 | ||
Constitutional UPD for chromosome 11p15 in individuals with isolated hemihyperplasia is associated with high tumor risk and occurs following assisted reproductive technologies. | Q53618272 | ||
Hyperinsulinemic hypoglycemia in Beckwith-Wiedemann, Sotos, and Kabuki syndromes: A nationwide survey in Japan. | Q54028104 | ||
Characterization of ABCC8 and KCNJ11 gene mutations and phenotypes in Korean patients with congenital hyperinsulinism. | Q54382062 | ||
Hypoglycemia in Kabuki syndrome. | Q54482735 | ||
Large Islets, Beta-Cell Proliferation, and a Glucokinase Mutation | Q55071701 | ||
Muscle glycogenosis due to phosphoglucomutase 1 deficiency | Q55670370 | ||
Hyperinsulinemic Hypoglycemia in Beckwith-Wiedemann Syndrome due to Defects in the Function of Pancreatic β-Cell Adenosine Triphosphate-Sensitive Potassium Channels | Q56111008 | ||
Three Human Glutamate Dehydrogenase Genes (GLUD1, GLUDP2, and GLUDP3) Are Located on Chromosome 10q, but Are Not Closely Physically Linked | Q57239996 | ||
Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. HI/HA Contributing Investigators | Q57499728 | ||
Functional Analysis of a Mutant Sulfonylurea Receptor, SUR1-R1420C, That Is Responsible for Persistent Hyperinsulinemic Hypoglycemia of Infancy | Q58449724 | ||
Intracellular ATP directly blocks K+ channels in pancreatic B-cells | Q59072807 | ||
Congenital Hyperinsulinism and Evolution to Sulfonylurearesponsive Diabetes Later in Life due to a Novel Homozygous p.L171F Mutation | Q64235767 | ||
Infantile lethal variant of Simpson-Golabi-Behmel syndrome associated with hydrops fetalis | Q70996226 | ||
Idiopathic spontaneously occurring hypoglycemia in infants; clinical significance of problem and treatment | Q73452280 | ||
Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: A new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose | Q78254436 | ||
Severe presentation of Beckwith-Wiedemann syndrome associated with high levels of constitutional paternal uniparental disomy for chromosome 11p15 | Q79829147 | ||
Hyperinsulinemic hypoglycemia in a newborn infant with trisomy 13 | Q80486169 | ||
Uncoupling protein-2 contributes significantly to high mitochondrial proton leak in INS-1E insulinoma cells and attenuates glucose-stimulated insulin secretion | Q81157112 | ||
Macrosomia and neonatal hypoglycaemia in RW pedigree subjects with a mutation (Q268X) in the gene encoding hepatocyte nuclear factor 4alpha (HNF4A) | Q81343830 | ||
20p11 deletion in a female child with panhypopituitarism, cleft lip and palate, dysmorphic facial features, global developmental delay and seizure disorder | Q83121006 | ||
Congenital hyperinsulinism in an infant with paternal uniparental disomy on chromosome 11p15: few clinical features suggestive of Beckwith-Wiedemann syndrome | Q85575314 | ||
Hyperinsulinemic hypoglycemia of infancy in Sotos syndrome | Q85651817 | ||
Delineation of a region responsible for panhypopituitarism in 20p11.2. | Q86748471 | ||
A case with neonatal hyperinsulinemic hypoglycemia: It is a characteristic complication of Sotos syndrome | Q86825143 | ||
Clinical and genetic evaluation of patients with KATP channel mutations from the German registry for congenital hyperinsulinism | Q87054603 | ||
The heterogeneity of hyperinsulinaemic hypoglycaemia in 19 patients with Beckwith-Wiedemann syndrome due to KvDMR1 hypomethylation | Q87173211 | ||
Neonatal case of novel KMT2D mutation in Kabuki syndrome with severe hypoglycemia | Q87248919 | ||
Congenital Hyperinsulinism in Infants with Turner Syndrome: Possible Association with Monosomy X and KDM6A Haploinsufficiency | Q89105315 | ||
Correction: "Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 10 affected individuals" | Q90879318 | ||
Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm | Q34370210 | ||
KCNQ1 long QT syndrome patients have hyperinsulinemia and symptomatic hypoglycemia | Q34393350 | ||
Congenital disorder of glycosylation id presenting with hyperinsulinemic hypoglycemia and islet cell hyperplasia | Q34412550 | ||
Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy | Q34502736 | ||
Mitochondrial GTP insensitivity contributes to hypoglycemia in hyperinsulinemia hyperammonemia by inhibiting glucagon release | Q34545472 | ||
Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development. | Q34657904 | ||
Genome-wide homozygosity analysis reveals HADH mutations as a common cause of diazoxide-responsive hyperinsulinemic-hypoglycemia in consanguineous pedigrees | Q35001535 | ||
Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics | Q35022156 | ||
Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1 | Q35043418 | ||
Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations | Q35201578 | ||
Multiple phenotypes in phosphoglucomutase 1 deficiency | Q35216844 | ||
Tissue-specific expression of glucokinase: identification of the gene product in liver and pancreatic islets | Q35596671 | ||
Hyperinsulinemic Hypoglycaemia in a Turner Syndrome with Ring (X). | Q35598895 | ||
Hyperinsulinism/hyperammonemia syndrome: insights into the regulatory role of glutamate dehydrogenase in ammonia metabolism | Q35722028 | ||
Dominantly acting ABCC8 mutations in patients with medically unresponsive hyperinsulinaemic hypoglycaemia | Q36032973 | ||
DNA methylation directs functional maturation of pancreatic β cells | Q36040239 | ||
Congenital hyperinsulinism and glycogenosis-like phenotype due to a novel HNF4A mutation | Q36292438 | ||
Congenital hyperinsulinism associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels: identification and rescue | Q36428374 | ||
Regulation of KATP channel activity by diazoxide and MgADP. Distinct functions of the two nucleotide binding folds of the sulfonylurea receptor | Q36436008 | ||
Open state destabilization by ATP occupancy is mechanism speeding burst exit underlying KATP channel inhibition by ATP. | Q36445257 | ||
Genotype and phenotype correlations in 417 children with congenital hyperinsulinism | Q36589427 | ||
Heterogeneity in phenotype of usher-congenital hyperinsulinism syndrome: hearing loss, retinitis pigmentosa, and hyperinsulinemic hypoglycemia ranging from severe to mild with conversion to diabetes | Q36629599 | ||
The inward rectifier potassium channel family. | Q36684014 | ||
Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism | Q36688839 | ||
Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders | Q36716020 | ||
L-glutamate dehydrogenases: distribution, properties and mechanism. | Q36761805 | ||
The molecular mechanisms, diagnosis and management of congenital hyperinsulinism | Q36862232 | ||
Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A. | Q36906935 | ||
Uncoupling proteins: role in insulin resistance and insulin insufficiency | Q37065665 | ||
Extremes of clinical and enzymatic phenotypes in children with hyperinsulinism caused by glucokinase activating mutations | Q37193748 | ||
Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism | Q37259401 | ||
Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. | Q37270892 | ||
Foxa2 regulates multiple pathways of insulin secretion. | Q37286330 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hyperinsulinism | Q477390 |
Hypoglycaemia | Q42004365 | ||
P304 | page(s) | 111 | |
P577 | publication date | 2019-01-01 | |
P1433 | published in | Frontiers in Endocrinology | Q27723680 |
P1476 | title | The Genetic and Molecular Mechanisms of Congenital Hyperinsulinism | |
P478 | volume | 10 |
Q90115285 | Hyperinsulinism associated with GLUD1 mutation: allosteric regulation and functional characterization of p.G446V glutamate dehydrogenase | cites work | P2860 |
Search more.